Sofia, Bulgaria, July 15, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on July 14, 2025 the Company sold 17 000 (seventeen thousand) repurchased own shares representing 0.01% of the share capital of the Company, at a total value of BGN 45 250.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.66.

Sofia, Bulgaria, July 14, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on July 11, 2025 the Company sold 2 000 (two thousand) repurchased own shares representing 0.001% of the share capital of the Company, at a total value of BGN 5 160.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.58.

София, Болгария, 10 июля 2025 г. – В соответствии с требованиями ст. 100т из ЗППЦБ, „Софарма“ АД (SFA: Болгарская фондовая биржа, SPH: Варшавская фондовая биржа) сообщает,

Sofia, Bulgaria, July 3, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on July 2, 2025 the Company sold 518 619  (five  hundred eighteen thousand six hundred and eighteen) repurchased own shares representing 0.29% of the share capital of the Company, at a total value of BGN 3 640 994.86 on the Bulgarian Stock Exchange, the average price per share was BGN 7.02.

Sofia, Bulgaria, July 2, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on July 1, 2025 the Company sold 500 (five hundred) repurchased own shares representing 0.0003% of the share capital of the Company, at a total value of BGN 3 600.00 on the Bulgarian Stock Exchange, the average price per share was BGN 7.20.

Sofia, Bulgaria, June 30, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on June 27, 2025 the Company sold 6 000 (six thousand) repurchased own shares representing 0.003% of the share capital of the Company, at a total value of BGN 39 760.00 on the Bulgarian Stock Exchange, the average price per share was BGN 6.63.